Dosage sensitivity is a major determinant of human copy number variant pathogenicity

Citations Over TimeTop 1% of 2017 papers

Abstract

Human copy number variants (CNVs) account for genome variation an order of magnitude larger than single-nucleotide polymorphisms. Although much of this variation has no phenotypic consequences, some variants have been associated with disease, in particular neurodevelopmental disorders. Pathogenic CNVs are typically very large and contain multiple genes, and understanding the cause of the pathogenicity remains a major challenge. Here we show that pathogenic CNVs are significantly enriched for genes involved in development and genes that have greater evolutionary copy number conservation across mammals, indicative of functional constraints. Conversely, genes found in benign CNV regions have more variable copy number. These evolutionary constraints are characteristic of genes in pathogenic CNVs and can only be explained by dosage sensitivity of those genes. These results implicate dosage sensitivity of individual genes as a common cause of CNV pathogenicity. These evolutionary metrics suggest a path to identifying disease genes in pathogenic CNVs.

Related Papers

• → Copy-Number Variation: The Balance between Gene Dosage and Expression in Drosophila melanogaster(2011)100 cited
• → Dosage Sensitivity Shapes the Evolution of Copy-Number Varied Regions(2010)96 cited
• The Copy Number Variation in the Human Genome and the Research and Development of New Drugs(2007)
• A versatile method for gene dosage quantification: multiplex PCR and single base extension for copy number and gene-conversion identification of SMN genes.(2018)
• → Copy Number Variation in the Human Genome(2021)